ASH Clinical News January 2016 | Page 3

VOLUME 02 | NUMBER 01 | JANUARY 2016 Around the Network AMERICAN SOCIETY OF HEMATOLOGY HEADQUARTERS 2021 L Street NW, Suite 900 Washington, DC 20036 www.hematology.org Tel: [phone] IN THIS ISSUE on location 57th ASH Annual Meeting EDITOR-IN-CHIEF Mikkael Sekeres, MD, MS The 2015 ASH Annual Meeting & Exposition featured practice-changing research from across the spectrum of hematologic malignancies and blood disorders. In this issue, we present highlights from the meeting, including new advances for the treatment of beta-thalassemia major, a discussion of the role of transplant in myeloma, and new treatments that lengthen the survival for patients with chronic lymphocytic leukemia. Vice-Chair for Clinical Research Director, Leukemia Program Cleveland Clinic, Taussig Cancer Institute Cleveland, OH ASSOCIATE EDITORS 38 Beth Faiman, CNP, PhD Cleveland Clinic Cleveland, OH Alice Ma, MD University of North Carolina School of Medicine Chapel Hill, NC David Steensma, MD Dana-Farber Cancer Institute Boston, MA Keith Stewart, MBChB, MBA Mayo Clinic Scottsdale, AZ PUBLISHER American Medical Communications Hematology Going Mobile Health-related mobile apps have proven popular with consumers, and physicians are beginning to integrate them into their practices as another tool to enhance patientphysician communication. But what are the drawbacks associated with the booming mobile health app market? And, even if patients are initially gung ho about downloading apps, are they using them with as much enthusiasm over time? We asked experts to weigh in. 50 clinical news 26 Hormonal Therapy Does Not Increase VTE Risk in Women on Anticoagulant Therapy 30 T  he Fresher the Better? How Does Age of Transfused Red Blood Cells Affect Patient Outcomes? 37 Carfilzomib Combination for Salvage Therapy in Multiple Myeloma: Results from a RealWorld Setting EDITORIAL MANAGING EDITORS Ariel Jones, AMC Karen Learner, ASH ASSOCIATE MANAGING EDITOR Kerri Fitzgerald, AMC ART DIRECTOR Ari Mihos ASSISTANT ART DIRECTORS Charlene DePrizio John Salesi DIGITAL PROJECTS MANAGER Chris Gedikli ADVERTISING ACCOUNT MANAGER Nick Luciano [email protected] Gene Conselyea [email protected] Recruitment advertising orders can be sent to: DIRECTOR, RECRUITMENT CLASSIFIEDS Lauren Morgan [email protected] Visit us at ashclinicalnews.org Follow us on Twitter @ASHClinicalNews ©2016 by the American Society of Hematology. All materials contained in this newsletter are protected by copyright laws and may not be used, reproduced, or otherwise exploited in any manner without the express prior written permission of ASH Clinical News. Any third-party materials communicated to ASH Clinical News become its copyrighted property and may be used, reproduced, or otherwise exploited by ASH Clinical News. ASHClinicalNews.org ASHCLINICALNEWS.ORG @ASHCLINICALNEWS The 57th ASH Annual Meeting & Exposition featured more than 4,500 abstracts and over 150 sessions. Since the average attendee likely couldn’t attend everything on his or her agenda, ASH Clinical News reported on the practice-changing science presented during the meeting. Check out our On Location section on page 38 for highlights from the meeting, and visit the “On Location” section of our website for our complete coverage, including exclusive content available only online: ashclinialnews.org/on-location. You can also hear from the presenters and experts we spoke with at the meeting by visiting our “Multimedia” section: ashclinicalnews.org/ multimedia/exclusive-videos. Search #ASH15 to catch up on what you missed at the annual meeting and make sure to follow us at: @ASHClinicalNews You can also sign up to receive our e-newsletters to have the latest updates from ASH Clinical News delivered to your inbox: ashclinicalnews.org/ enewsletter-sign-up Subscription inquiries should be sent to: [email protected] All correspondence for the American Society of Hematology should be sent to: American Society of Hematology, 2021 L Street NW, Suite 900, Washington DC 20036. Neither the American Society of Hematology nor the publisher is responsible for statements made by any editor or contributor. Statements, editorials, or opinions express VB